Eton Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ETON
CUSIP
29772L108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 29772L108 since 12/18/2024, largest first.

Filer % of Class Filed
EcoR1 Capital, LLC 13G/A
7.7% 2/14/2025
Event 12/31/2024
BlackRock, Inc. 13G/A 6.9% 7/28/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 19 294 k $15.1 M
2026 Q2 174 21.2 M $767 M
2026 Q1 124 17.8 M $439 M
2025 Q4 110 16.4 M $278 M
2025 Q3 108 18.5 M $406 M
2025 Q2 93 17.1 M $243 M
2025 Q1 92 14.6 M $190 M
2024 Q4 77 13.6 M $182 M
2024 Q3 55 10.0 M $60.0 M
2024 Q2 53 9.86 M $32.4 M
2024 Q1 51 7.69 M $28.9 M
2023 Q4 62 7.65 M $33.5 M
2023 Q3 55 6.90 M $28.8 M
2023 Q2 37 5.98 M $20.9 M
2023 Q1 39 5.84 M $22.5 M
2022 Q4 35 6.01 M $18.3 M
2022 Q3 35 6.34 M $14.4 M
2022 Q2 33 5.92 M $17.7 M
2022 Q1 37 5.78 M $27.4 M
2021 Q4 41 5.75 M $27.2 M
2021 Q3 43 5.96 M $32.6 M
2021 Q2 52 6.84 M $51.8 M
2021 Q1 53 8.79 M $68.0 M
2020 Q4 49 8.73 M $75.0 M
2020 Q3 41 7.04 M $59.5 M
2020 Q2 43 6.80 M $39.8 M
2020 Q1 19 5.97 M $24.5 M
2019 Q4 15 2.62 M $18.9 M
2019 Q3 15 2.28 M $14.4 M
2019 Q2 11 1.77 M $14.0 M
2019 Q1 13 1.50 M $12.0 M
2018 Q4 13 1.15 M $7.05 M